Suche nachMaren C. Perry

Region
Status
Waren und Dienstleistungen

Ihre Suche hat mehr als 1000 Treffer ergeben. Bitte filtern Sie die Ergebnisse, um die Anzahl der Treffer zu reduzieren.

Land
Aktenzeichen
Marke
Klasse(n)
Inhaber
Anmeldung
Eintragung
Schutzende
Status
USPTO
87633378
1352930313233
October's Very Own IP Holdings
04.10.2017
-
-
SUSPENSION LETTER - MAILED
USPTO
90172587
3642
FundersClub Inc.
10.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90167552
MVP MIGRAINE VICTORS PROGRAM
4145
Lundbeck Seattle BioPharmaceuticals, Inc.
09.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90167555
MVP MIGRAINE VICTORS PROGRAM
4145
Lundbeck Seattle BioPharmaceuticals, Inc.
09.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90159397
ATTACK PETER
18
Skybound, LLC
04.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90159403
ATTACK PETER
20
Skybound, LLC
04.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90159435
ATTACK PETER
16
Skybound, LLC
04.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90159455
ATTACK PETER
25
Skybound, LLC
04.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90160719
D
5
Revance Therapeutics, Inc.
04.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90153630
CHEMISTRYMATTERS
544
Revance Therapeutics, Inc.
02.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

Darum lohnt sich ein kostenfreier TMDB Account

Marken überwachen und schützen

Wenn Sie eine Markenüberwachung eingerichtet haben, erhalten Sie automatisch eine E-Mail über Nachahmer und Trittbrettfahrer. So funktioniert unkomplizierter Markenschutz in Echtzeit.

Marken ganz einfach folgen

Wenn Sie einer Marke folgen, erhalten Sie eine E-Mail bei neuen Anmeldungen, Widersprüchen, Fristen und Verlängerungen u.v.m. – So bleiben Sie auf dem Laufenden was die Entwicklung einer Marke angeht.

Kostenfrei registrieren
USPTO
90150834
MIGRAINE VICTORS PROGRAM
4145
Lundbeck Seattle BioPharmaceuticals, Inc.
01.09.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90136402
HADJI GAVIOTA
41
Mark Paraskevas
25.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90128803
TWICE UPON A TIME
5
Revance Therapeutics, Inc.
21.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90128805
DAXXIFY. IT'S ABOUT TIME.
5
Revance Therapeutics, Inc.
21.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90121948
BEAUTY AND THE BROW
5
Revance Therapeutics, Inc.
18.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90117068
SWIFTPAY
9
Washify Services, LLC
16.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90117070
SWIFTPAY
35
Washify Services, LLC
16.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90117074
SWIFTPAY
42
Washify Services, LLC
16.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90115561
SWIFTPAY
9
Washify Services, LLC
14.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90115565
SWIFTPAY
35
Washify Services, LLC
14.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90115571
SWIFTPAY
42
Washify Services, LLC
14.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90106769
PREVU
41
Revance Therapeutics, Inc.
11.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90106803
U REVANCEU
41
Revance Therapeutics, Inc.
11.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90106821
U REVANCEU STUDIO
41
Revance Therapeutics, Inc.
11.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90106834
REVANCEU STUDIO
41
Revance Therapeutics, Inc.
11.08.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90078705
OPUL
353642
Revance Therapeutics, Inc.
28.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90072517
FLAWLESS IN MOTION
44
Revance Therapeutics, Inc.
24.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90066651
LIFELINE PRO
10
Defibtech, LLC
22.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90052252
REVANCEU
41
Revance Therapeutics, Inc.
14.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90051680
TREE LINE CAPITAL PARTNERS
36
Tree Line Capital Partners, LLC
14.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90030921
THE WALKING DEAD UNIVERSE
9163541
Robert Kirkman, LLC
01.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90030942
TWD UNIVERSE
91621253541
Robert Kirkman, LLC
01.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90030954
TWDU
91621253541
Robert Kirkman, LLC
01.07.2020
-
-
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
USPTO
90022083
VYEPTI GO
44
Lundbeck Seattle BioPharmaceuticals, Inc.
26.06.2020
-
-
NON-FINAL ACTION - MAILED
USPTO
90022194
VYEPTI GO
44
Lundbeck Seattle BioPharmaceuticals, Inc.
26.06.2020
-
-
NON-FINAL ACTION - MAILED
USPTO
90022226
VYEPTI CONNECT
3536
Lundbeck Seattle BioPharmaceuticals, Inc.
26.06.2020
-
-
PRIORITY ACTION MAILED
USPTO
90003778
NORAGH'S OTTER ANALYTICS
9354245
Noragh Analytics, Inc.
16.06.2020
-
-
NEW APPLICATION - ASSIGNED TO EXAMINER
USPTO
88960834
93542
Featurespace Limited
11.06.2020
-
-
NON-FINAL ACTION - MAILED
USPTO
88950356
AMDL
93542
Featurespace Limited
05.06.2020
-
-
NON-FINAL ACTION - MAILED
USPTO
88897825
VYEPTI CONNECT
3536
Lundbeck Seattle BioPharmaceuticals, Inc.
01.05.2020
-
-
PRIORITY ACTION MAILED

Suchergebnisse 1 - 41 von 1000+

Wir lieben Marken.
Und betreuen Sie gerne.

Sie erreichen uns von Montag bis Freitag zwischen 08:00–16:00 Uhr.

Kontaktieren Sie uns.

Wir verwenden Cookies, um Ihre Einstellungen und Statistiken zu speichern und unseren Inhalt zu verbessern. Durch Klicken auf "Alle akzeptieren" akzeptieren Sie die Verwendung von Cookies.

Akzeptieren